Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma
by on Tuesday, August 7th, 2012 | No Comments
Condition: Metastatic Melanoma
Interventions: Drug: High Dose Interleukin-2 (IL-2); Procedure: ACT with TIL Infusion; Drug: Vemurafenib; Drug: Lymphodepletion
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; H. Lee Moffitt Cancer Center and Research Institute
Recruiting – verified August 2012
Continue reading here: Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma